Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Optimization of Diagnosis and Treatment of Depression Based on Multidimensional Clinical Assessment
NCT04528628Unknown
- Sponsor
- Shanghai Mental Health Center
- Start
- Oct 2020
- Primary completion
- Sep 2022
- Countries
- 1
01
Overview
Randomised trial in major depressive disorder (MDD), sponsored by Shanghai Mental Health Center. Primary endpoint: remission of acute phase at 12 weeks. Status: unknown.
02
Conditions
major depressive disorder (MDD)
Beyond the preview
Go deeper on NCT04528628.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04528628.